1. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial. Issue 1 (January 2023) Authors: Lanfranconi, Silvia; Scola, Elisa; Meessen, Jennifer M T A; Pallini, Roberto; Bertani, Giulio A; Al-Shahi Salman, Rustam; Dejana, Elisabetta; Latini, Roberto; Abete Fornara, Giorgia; Agnelli, Nicolò M.; Albanese, Alessio; Awad, Issam; Bagnati, Renzo; Balconi, Giovanna; Ballabio, Elena; Beghi, Ett... Journal: Lancet neurology Issue: Volume 22:Issue 1(2023) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗